BTIG Upgrades Zimmer Biomet Holdings to Buy, Announces $139 Price Target
Portfolio Pulse from richadhand@benzinga.com
BTIG analyst Ryan Zimmerman has upgraded Zimmer Biomet Holdings (NYSE:ZBH) from Neutral to Buy and set a price target of $139.
August 28, 2023 | 9:54 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Zimmer Biomet Holdings has been upgraded from Neutral to Buy by BTIG analyst Ryan Zimmerman, with a new price target of $139.
The upgrade from Neutral to Buy indicates a positive outlook for Zimmer Biomet Holdings. The new price target of $139 suggests that the analyst expects the stock to rise in the short term. This could potentially lead to an increase in the stock's price as investors react to the news.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100